Columbia Laboratories Acquires Molecular Profiles

Published on: 

Columbia Laboratories acquires Molecular Profiles in multimillion-dollar deal.

Columbia Laboratories has acquired Molecular Profiles, a UK-based pharmaceutical development services company, for approximately $25 million.

This acquisition was unanimously approved by the boards of directors of both companies and received the approval of Molecular Profiles’ shareholders. No further approvals are anticipated to be required.

According to the company, Molecular Profiles’ recorded approximately $9 million in revenues for its fiscal year ended July 31, 2013.


Source: Columbia Laboratories